Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥10,077 | CN¥15,118 | CN¥13,377 | CN¥12,659 |
| - Cash | CN¥756 | CN¥644 | CN¥1,022 | CN¥827 |
| + Debt | CN¥785 | CN¥792 | CN¥636 | CN¥1,049 |
| Enterprise Value | CN¥10,105 | CN¥15,266 | CN¥12,991 | CN¥12,882 |
| Revenue | CN¥2,869 | CN¥3,276 | CN¥3,583 | CN¥3,912 |
| % Growth | -12.4% | -8.6% | -8.4% | – |
| Gross Profit | CN¥1,348 | CN¥1,354 | CN¥1,532 | CN¥1,588 |
| % Margin | 47% | 41.3% | 42.8% | 40.6% |
| EBITDA | CN¥433 | CN¥512 | CN¥672 | CN¥728 |
| % Margin | 15.1% | 15.6% | 18.8% | 18.6% |
| Net Income | CN¥184 | CN¥210 | CN¥307 | CN¥152 |
| % Margin | 6.4% | 6.4% | 8.6% | 3.9% |
| EPS Diluted | 0.223 | 0.254 | 0.38 | 0.189 |
| % Growth | -12.4% | -33.1% | 101.2% | – |
| Operating Cash Flow | CN¥287 | CN¥277 | CN¥997 | CN¥944 |
| Capital Expenditures | -CN¥456 | -CN¥512 | -CN¥390 | -CN¥530 |
| Free Cash Flow | -CN¥169 | -CN¥235 | CN¥607 | CN¥413 |